Related references
Note: Only part of the references are listed.Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences A Randomized Clinical Trial
Anna Wald et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy
Paul T. Edlefsen et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
2014 UK national guideline for the management of anogenital herpes
Raj Patel et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2015)
Helicase-Primase as a Target of New Therapies for Herpes Simplex Virus Infections
S. H. James et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Helicase-Primase Inhibitor Pritelivir for HSV-2 Infection
Anna Wald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Resistance to antiviral drugs in herpes simplex virus infections among allogeneic stem cell transplant recipients: Risk factors and prognostic significance
S Chakrabarti et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
